文献速递系统性红斑狼疮

羟氯喹改善低补体水平

Hydroxychloroquine Improves Low Complement Levels.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2024-07-02

研究基于前瞻性收集的系统性红斑狼疮(SLE)队列数据,分析起始羟氯喹(HCQ)者与未起始者的补体变化,并用条件logistic回归评估全血HCQ水平与低补体水平的关联。结果显示起始HCQ者C4正常化比例更高(40% vs 13%,P=0.011),C3、C4升高更显著(P=0.048、P=0.017);全血HCQ水平较高时C4正常概率更高(OR 1.8–2.6),在≥200 ng/mL时最明显。

要点

  • 起始HCQ者C4正常化比例40%(23/57)vs 未起始者13%(9/56),P=0.011。
  • 起始HCQ者C3和C4水平升高均显著高于未起始者(P=0.048和P=0.017)。
  • 全血HCQ水平较高时C4正常概率更高(OR 1.8–2.6),≥200 ng/mL时最明显。

核心结论

  • 起始HCQ及全血HCQ水平较高时补体水平显著改善,尤其体现在C4。
  • 调节导致补体消耗的致病机制可能是HCQ预防SLE不良结局的方式之一。

研究设计与样本

  • 对前瞻性收集的SLE队列数据进行两项分析:第一项为「新起始HCQ」分析,比较起始与未起始HCQ者的补体水平变化;第二项分析用条件logistic回归评估全队列访视中全血HCQ水平与低补体水平的关联。

主要发现

  • 「新起始HCQ」分析中,起始HCQ者(以HCQ血药水平>50反映)C4正常化比例高于未起始者(23/57[40%] vs 9/56[13%];P=0.011)。
  • 「新起始HCQ」分析中,起始HCQ者C3和C4水平升高均显著大于未起始者(P=0.048和P=0.017)。
  • 「全队列访视」分析中,HCQ全血水平较高的访视C4正常概率显著更高(OR 1.8–2.6,取决于水平)。
  • 上述关联在HCQ全血水平≥200 ng/mL时最明显。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Having a low complement level is associated with clinical systemic lupus erythematosus (SLE) disease activity and future organ damage. We studied the association of hydroxychloroquine (HCQ) whole blood levels with changes in complement level. METHODS: We performed two analyses on data prospectively collected from an SLE cohort. In the first (a "new starts on HCQ" analysis), we compared changes in complement level between those starting HCQ and those not starting it. The second analysis evaluated the association between HCQ whole blood levels and low complement level in all cohort visits using conditional logistic regression. RESULTS: In the "new starts on HCQ" analysis, a higher percentage of patients starting HCQ (as reflected in HCQ blood levels >50) experienced a normalization of C4 level compared to those not starting HCQ (23 of 57 [40%] vs. 9 of 56 [13%]; P = 0.011), as well as a significantly greater increase in both C3 and C4 level (P = 0.048 and P = 0.017, respectively). In the "all cohort visits" analysis, there was a statistically significant higher probability of having normal C4 levels in visits with higher HCQ whole blood levels (odds ratio 1.8-2.6 depending on the levels). This relationship was most pronounced for whole blood HCQ levels of 200 ng/mL or more. CONCLUSION: We observed significant improvement in complement levels when HCQ was started and among those with higher whole blood levels of HCQ, particularly with respect to C4. Modulating the pathogenic mechanisms that lead to complement consumption may be one mode by which HCQ prevents poor outcomes in SLE.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Jacobson R, Goldman D, Fava A, et al. Hydroxychloroquine Improves Low Complement Levels. Arthritis Care Res (Hoboken). 2024. PMID: 38831658. doi:10.1002/acr.25381

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。